Financial results for Q2 2022 just released: Temporary suspension of full-year outlook maintained
NNIT announced the transformative divestment of the Group’s infrastructure business, initiated the carve-out process and continued the efforts to consolidate global delivery capabilities in Q2 2022, which was marked by slower-than-expected sales performance. The temporary suspension of NNIT’s full-year outlook is maintained.
NNIT divests infrastructure operations and suspends 2022 guidance
Today, NNIT has entered into an agreement to divest its Hybrid Cloud Solutions business unit as well as select parts of its Cloud & Digital Solutions business unit (together “the IO business”) to funds advised by Agilitas Private Equity LLP.
Financial results for Q1 2022 just released: Maintaining full-year outlook
In Q1 2022, NNIT saw a decline in revenue and earnings mainly due to a temporary decline in capacity utilization. Positively, a number of significant contracts were signed, and strategic initiatives progressed as planned. Outlook for the full-year is maintained.
Excellis Health Solutions – An NNIT Group Company
NNIT has evolved quite dramatically over the years, from a small independent IT consultancy born out of Novo Nordisk to a publicly listed company and now an international group of companies in its own right. This article is the fourth in a series looking at the individual NNIT Group Companies – what they do and how they add value to NNIT’s purpose and aspiration of making a mark in business and so
NNIT appoints new Senior Vice President of People, Communications & Marketing
NNIT has appointed Camilla G. Møhl as its new SVP and Chief People, Communications and Marketing Officer. She will join NNIT Group Management no later than May 1, 2022.
The NNIT Group acquires prime4services and further boosts its Production IT offering to the life sciences industry
With the acquisition of prime4services, Europe's leading provider of Manufacturing Execution System services, the NNIT Group further solidifies its position within the international life sciences industry.
prime4services operates solely within the life sciences industry providing supplier-independent consulting and engineering services for digitalization of manufacturing processes, primarily th
Financial results for Q4 2021 just released: In line with expectations
In Q4, we saw continued strong growth within the Life Sciences International business while performance within the Private & Public segment remained weak. Once again, our Winning Solutions strategy gained traction, as it now constitutes 55% of NNIT’s revenue compared to 46% in the same period last year.
New organization to enable future profitable growth
As of January 1, 2022, NNIT will reorganize into three business units: Life Sciences Solutions, Cloud & Digital Solutions and Hybrid Cloud Solutions. The new organization will further strengthen NNIT’s focus on aligning customers and segments closer with preferred solutions and positioning the company for future profitable growth.
Financial results for Q3 2021 just released: Group revenue increase of 6.1% countered by lower profit margin
In Q3, we saw continued strong growth within the Life Sciences International business, and we strengthened this business further with the addition of SL Controls. Once again, our Winning Solutions strategy gained traction, as it now constitutes 54% of NNIT’s revenue compared to 46% in the same period last year.
Valiance – An NNIT Group Company
NNIT has evolved quite dramatically over the years, from a small independent IT consultancy born out of Novo Nordisk to a publicly listed company and now an international group of companies in its own right. This article is the second in a series looking at the individual NNIT Group Companies.
Life sciences companies need to take further steps to protect themselves against the growing problem of counterfeit drugs
When talking about counterfeiting, most of us think about major consumer brands but, unfortunately, counterfeiting is also a major and growing problem within the life sciences industry – and to make matters worse, nobody knows exactly how big the problem is.